Log in
NYSEARCA:GERM

ETFMG Treatments, Testing and Advancements ETF Stock Forecast, Price & News

$28.49
+0.61 (+2.19 %)
(As of 10/22/2020 12:00 AM ET)
Add
Today's Range
$28.05
Now: $28.49
$28.50
50-Day Range
$24.63
MA: $27.57
$30.26
52-Week Range
$23.80
Now: $28.49
$35.15
Volume56,226 shs
Average Volume105,963 shs
Market Capitalization$55.56 million
P/E RatioN/A
Dividend Yield0.00%
BetaN/A

Geographic Exposure of GERM

Currency Exposure of GERM

Sector Exposure of GERM

Industry Exposure of GERM

Basic Details

Issuer ETF Managers Group
Fund NameETFMG Treatments Testing and Advancements ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:GERM
Inception Date6/17/2020
Fund ManagerSamuel Masucci, Frank Vallario, Donal A. Bishnoi, Devin Ryder
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkPrime Treatments, Testing and Advancements Index
CategoryStrategy
FocusTheme
Development LevelBlended Development
RegionGlobal

Fund Statistics

Assets Under Management$58.36 million
Average Daily Volume$0.00
Discount/Premium0.00%

ETF Expenses

Management Fee0.68%
Other Expenses0.00%
Total Expenses0.68%
Fee Waiver0.00%
Net Expenses0.68%

Administrator, Advisor and Custodian

AdministratorU.S. Bancorp Fund Services, LLC
AdvisorETF Managers Group, LLC
CustodianU.S. Bank, N.A.
DistributorETFMG Financial LLC
Transfer AgentU.S. Bank, N.A.
Trustee
Lead Market Maker
$28.49
+0.61 (+2.19 %)
(As of 10/22/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive GERM News and Ratings via Email

Sign-up to receive the latest news and ratings for GERM and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











ETFMG Treatments, Testing and Advancements ETF (NYSEARCA:GERM) Frequently Asked Questions

What other stocks do shareholders of ETFMG Treatments, Testing and Advancements ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ETFMG Treatments, Testing and Advancements ETF investors own include Village Farms International (VFF), Charlotte's Web (CWBHF), 3 Sixty Risk Solutions (PTVYF), Aphria (APHA), Inovio Pharmaceuticals (INO), Moderna (MRNA), Paypal (PYPL), AbbVie (ABBV), Brookfield Property Partners (BPY) and Auxly Cannabis Group (CBWTF).

What is ETFMG Treatments, Testing and Advancements ETF's stock symbol?

ETFMG Treatments, Testing and Advancements ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "GERM."

How do I buy shares of ETFMG Treatments, Testing and Advancements ETF?

Shares of GERM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is ETFMG Treatments, Testing and Advancements ETF's stock price today?

One share of GERM stock can currently be purchased for approximately $28.49.

How big of a company is ETFMG Treatments, Testing and Advancements ETF?

ETFMG Treatments, Testing and Advancements ETF has a market capitalization of $55.56 million.

This page was last updated on 10/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.